Re-audit of revised method for assessing the mitotic component of histological grade in needle core biopsies of invasive carcinoma of the breast

Histopathology

Volumn 60, Issue 7, 2012, Pages 1166-1167

  Lee, Andrew H S ^a   Rakha, Emad A ^a   Hodi, Zsolt ^a   Ellis, Ian O ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CARCINOMA; CANCER GRADING; CANCER SURGERY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; INVASIVE CARCINOMA; LETTER; MITOSIS; NEEDLE BIOPSY; PATIENT ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM;

BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MITOSIS; MITOTIC INDEX; NEOPLASM INVASIVENESS;

EID: 84861481278     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2012.04216.x     Document Type: Letter

References (5)

1. O'Leary R, Hawkins K, Beazley JC, Lansdown MR, Hanby AM. Agreement between preoperative core needle biopsy and postoperative invasive breast cancer histopathology is not dependent on the amount of clinical material obtained. J. Clin. Pathol. 2004; 57; 193-195.
2. Usami S, Moriya T, Amari M et al. Reliability of prognostic factors in breast carcinoma determined by core needle biopsy. Jpn. J. Clin. Oncol. 2007; 37; 250-255.
3. O'Shea AM, Rakha EA, Hodi Z, Ellis IO, Lee AHS. Histological grade of invasive carcinoma of the breast assessed on needle core biopsy-modifications to mitotic count assessment to improve agreement with surgical specimen. Histopathology 2011; 59; 543-548.
4. Harris GC, Denley HE, Pinder SE et al. Correlation of histologic prognostic factors in core biopsies and therapeutic excisions of invasive breast carcinoma. Am. J. Surg. Pathol. 2003; 27; 11-15.
5. National Co-Ordinating Group for Breast Screening pathology. Pathology reporting of breast disease, 3rd edn. Sheffield & London: NHS Cancer Screening Programmes & The Royal College of Pathologists, 2005. Available at: (accessed 15 December 2011).